Cite
HARVARD Citation
Zbieg, J. et al. (2021). Discovery of GNE-502 as an orally bioavailable and potent degrader for estrogen receptor positive breast cancer. Bioorganic & medicinal chemistry letters. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zbieg, J. et al. (2021). Discovery of GNE-502 as an orally bioavailable and potent degrader for estrogen receptor positive breast cancer. Bioorganic & medicinal chemistry letters. p. . [Online].